Performance of the 1 h oral glucose tolerance test in predicting type 2 diabetes and association with impaired β-cell function in Asians: a national prospective cohort study
National Medical Research Council (NMRC), Ministry of Health (MOH; Singapore) Industry Alignment Fund [NMRC/MOHIAFCat1/0048/2016] and Janssen Pharmaceuticals Inc. (USA).
Authors
- Faidon Magkos (ORCID: https://orcid.org/0000-0002-1312-7364)
- Maybritte Lim
- Sue‐Anne Toh (ORCID: https://orcid.org/0000-0003-1570-4417)
- Liang Shen (ORCID: https://orcid.org/0000-0001-7976-668X)
- Tze Ping Loh (ORCID: https://orcid.org/0000-0002-4272-0001)
- Mayank Dalakoti (ORCID: https://orcid.org/0000-0002-7091-7880)
- Mark Y. Chan (ORCID: https://orcid.org/0000-0003-0389-7450)
- Kee Seng Chia (ORCID: https://orcid.org/0000-0002-0629-5570)
- Nicholas Chew (ORCID: https://orcid.org/0000-0002-0640-0430)
- Sonia Baig (ORCID: https://orcid.org/0000-0001-5195-3512)
- Alex R. Cook (ORCID: https://orcid.org/0000-0002-6271-5832)
- Eveline Febriana (ORCID: https://orcid.org/0009-0004-8912-1702)
- Alice Pik-Shan Kong
- Michelle H. Lee (ORCID: https://orcid.org/0000-0003-2703-7308)
- Jeffrey B. Halter
Institutions
- University of Copenhagen (DK)
- National University of Singapore (SG)
- Chinese University of Hong Kong (HK)
- University of Michigan (US)
- Ng Teng Fong General Hospital (SG)
- National University Heart Centre Singapore (SG)
- National University Hospital (SG)
- National University Health System (SG)
Publication Details
- Journal
- The Lancet Regional Health - Western Pacific
- Published
- 2024-12-31
- DOI
- https://doi.org/10.1016/j.lanwpc.2024.101278
- Citations
- 2
- Primary Topic
- Diabetes, Cardiovascular Risks, and Lipoproteins
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Ministry of Health
- National University of Singapore
- Jeju National University Hospital
- National University Health System
- Medical Research Council
- National Medical Research Council
- Janssen Pharmaceuticals